US about to ok adjuvanted flu vaccines?

'Flu »

There has been some discussion in the past about utilizing adjuvants, most notably when the swine flu epidemic of 2009 prompted concerns about the availability of vaccine. However, public health officials decided against it because the regular vaccine seemed to be effective, and they felt the adjuvant had not yet been tested adequately despite scientific evidence showing the vaccine’s safety, MSNBC Health News, 6/1/2011. Read more…

The article quoted William Schaffner, chairman of preventive medicine at Vanderbilt University School of Medicine that most think adjuvanted vaccines add effectiveness and the capacity to more rapidly deliver vaccines – a method used in Europe for more than a decade to date.

How has the US FDA considered all of these?

How many more tests have been done to prove the safety of these vaccines?

What are the results of those tests?

All these and a side-by-side discussion on adjuvanted flu vaccines by FDA’s Norman Baylor and EMA’s Pieter Neels will be presented at the 3rd Annual Influenza Congress USA.